---
schema_version: "secwatch.filing_event.v1"
accession: "0001367644-23-000160"
form_type: "8-K"
ticker: "EBS"
cik: "0001367644"
company_name: "Emergent BioSolutions Inc."
filed_at: "2023-08-16T23:59:59+00:00"
generated_at: "2026-06-11T08:18:01.660699+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Emergent BioSolutions announces death of director Dr. Jerome Hauer on Aug 11, 2023

## Summary
- Dr. Jerome Hauer, director since January 2015 (previously 2004-2011), passed away August 11, 2023 after a battle with cancer.
- No replacement for the vacant board seat has been announced as of the filing date.
- Company issued a statement honoring Hauer's public health career and expressing condolences.

## SEC filing metadata
- accession: 0001367644-23-000160
- form_type: 8-K
- ticker: EBS
- cik: 0001367644
- company_name: Emergent BioSolutions Inc.
- filed_at: 2023-08-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367644/000136764423000160/0001367644-23-000160-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367644/000136764423000160/ebs-20230811.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001367644-23-000160
- JSON: https://secwatch.observer/filing/0001367644-23-000160.json
- Plain text: https://secwatch.observer/filing/0001367644-23-000160.txt

## Key facts
- Executive change
  Jerome Hauer departed as director at Emergent BioSolutions Inc..
  - Action: passed away
  - Role: director
  source text: On August 16, 2023, Emergent BioSolutions Inc. (the “Company”), announced that Jerome Hauer, Ph.D., a director of the Company, had passed away on Friday August 11, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1367644/000136764423000160/0001367644-23-000160-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.